Reagent Kit for Immunodiagnostic Detection of SARS-CoV-2 Nucleocapsid Antigen in Nasopharyngeal and Oropharyngeal Swabs via Enhanced Chemiluminescence on VITROS Analyzers, Lot: 0051, 0053

Reagent Kit for Immunodiagnostic Detection of SARS-CoV-2 Nucleocapsid Antigen in Nasopharyngeal and Oropharyngeal Swabs via Enhanced Chemiluminescence on VITROS Analyzers, Lot: 0051, 0053

Immunodiagnostic Reagent Kit for SARS-CoV-2 Nucleocapsid Antigen Detection

This reagent kit is designed for the immunodiagnostic detection of the SARS-CoV-2 nucleocapsid antigen in nasopharyngeal and oropharyngeal swabs using the enhanced chemiluminescence method on VITROS analyzer systems.

Kit Contents:

• VITROS SARS-CoV-2 Antigen Reagent Pack – 1 unit (Lot 0051 or Lot 0053)
  Designed for the immunodiagnostic detection of the SARS-CoV-2 nucleocapsid antigen in a cassette format, compatible with VITROS series analyzers.
• VITROS SARS-CoV-2 Antigen Extraction Buffer – up to 1 unit (Lot 0012)
  Supplied as four 28 ml bottles (used as needed) for viral antigen extraction from nasopharyngeal and oropharyngeal swabs.
• User Manual – 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Immunodiagnostic Detection of SARS-CoV-2 Nucleocapsid Antigen in Nasopharyngeal and Oropharyngeal Swabs via Enhanced Chemiluminescence on VITROS Analyzers, Lot: 0051, 0053, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.